Clinical trial

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

NCT01434342

Study summary

ClinicalTrials.gov

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Nicotine Replacement Patch Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-10-01

PhaseEARLY_PHASE1

Conditions

Lung Cancerverified · MONDO: lung cancer

Tobacco Use Disorderunresolved

Breast Cancerverified · MONDO: breast cancer

Colorectal Cancerverified · MONDO: colorectal cancer

Prostate Cancerverified · MONDO: prostate cancer

Interventions

Nicotine Replacement PatchDRUG

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01434342 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.